Therefore, knockdown of GUSB in cancer cells can 1) inhibit the growth of cancer cells, 2) increase NK and CD8+ T cells in the tumor microenvironment and decrease immunosuppressive cells such as Tregs and M2 macrophages. The gene discussed is GUSB; the disease is neoplasm.